Lyrica
NDC Package 68258-7980-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lyrica is a medication used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Marketed by Dispensing Solutions, Inc., this product is identified by NDC 68258-7980 and is authorized under FDA application NDA021724.

Identification & Billing

NDC Package Code
68258-7980-9
Package Description
90 CAPSULE in 1 BOTTLE
Product Code
68258-7980
11-Digit Billing Format
68258798009
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lyrica
Dosage Form
-
Usage Information
This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Regulatory & Marketing

Labeler Name
Dispensing Solutions, Inc.
FDA Application #
NDA021724
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-30-2004
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68258-7980-9 identifies a specific commercial package of 90 capsule in 1 bottle of Lyrica, labeled by Dispensing Solutions, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dispensing Solutions, Inc. on December 30, 2004. The current certification is valid through December 31, 2017.

What are the primary indications for this medication?

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

How is this Dispensing Solutions, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68258798009. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68258-7980-9
11-Digit CMS (5-4-2)
68258-7980-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.